Sarepta to Have Flu Drug Candidate Tested by NIH

Sarepta to have flu drug candidate tested by NIH

Filed under: drug treatment programs in maryland

Cambridge-based Sarepta Therapeutics Inc. (Nasdaq: SRPT), which is developing a gene-based treatment aimed at Duchenne muscular dystropy (DMD), is collaborating with the National Institutes of Health (NIH) for a Phase I study of a drug to treat …
Read more on Bizjournals.com (blog)

Big pharma cashing in on HGH abuse

Filed under: drug treatment programs in maryland

In other cases, the drug was used "for an unknown indication," meaning that the reason for treatment wasn't clear. Even Medicare, the government health program for older Americans, allowed 22,169 HGH prescriptions in 2010, a five-year increase of 78 …
Read more on SI.com

Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition

Filed under: drug treatment programs in maryland

"Diazepam Nasal Spray is an important addition to our pipeline and aligns with our core strategy to develop and commercialize products that offer unique benefits to people with neurological diseases," said Ron Cohen, M.D., Acorda's President and CEO …
Read more on DailyFinance